... J Cancer 2001, 94:153-156.2. Non -small CellLungCancer Collaborative Group: Chemotherapyin non smallcelllung cancer: a meta-analysis using updateddata on individual patients from 52 randomized ... Tonato M: Gemcitabine and cisplatin versus mito-mycin, ifosfamide, and cisplatin in advanced non -small- cell lung cancer: a randomized phase III study of the Italian Lung Cancer Project. J Clin ... sur-vival and improve quality of life in non -small celllung cancer: a review of the literature and future directions. Clin Cancer Res1998, 4:1087-1100.4. Le Chevalier T, Brisgand D, Douillard...
... stage smallcelllung cancer. Int J Radiat Oncol Biol Phys 1999, 43:39-45.31. Rancati T, Ceresoli GL, Gagliardi G, Schipani S, Cattaneo GM: Factors predicting radiation pneumonitis in lungcancer ... locally advanced non -small celllungcancer treated with concurrent chemotherapy and intensity-modulated radiotherapyAnhui Shi, Guangying Zhu*, Hao Wu, Rong Yu, Fuhai Li and Bo XuAbstractBackground: ... dosimetric factors and severe acute radiation pneumonitis (SARP) in patients with locally advanced non -small celllungcancer (LANSCLC) treated with concurrent chemotherapy and intensity-modulated...
... mutations in lungcancer patients.Methods: EGFR mutation status was analyzed by DNA assays, and compared with IHC results in five non -small- cell lungcancer (NSCLC) cell lines and tumor samples ... Non -small- celllungcancer harbouring mutations in the EGFRkinase domain. Clin Transl Oncol 2010, 12:75-80.9. Gazdar AF: Activating and resistance mutations of EGFR in non -small- cell lung cancer: ... analyses [10,11].MethodsSources of cell lines and cultureThe PC-9 lung tumor cell line was kindly provided byRoche (Basel, Switzerland); the A549 and H460 cell lineswere purchased from the...
... and for clinical-pathological reasons are often dividedinto two broad categories: smallcelllungcancer (SCLC) and non -small celllungcancer (NSCLC). All majorhistological types of lungcancer ... oesophagus, head and neck cancer. HPV has also been speculated to have a role in the pathogenesis of lung cancer. To validate thehypothesis of HPV involvement in smallcelllungcancer pathogenesis ... pathogenesis of lung cancer. Annu Rev Physiol 2002, 64:681-708.13. Syrianen KJ: HPV infections andlung cancer. J Clin Pathol 2002,55:885-891.14. zur Hausen H: Papillomaviruses and cancer: from...
... tumor cells versus stromal cells in non small celllung cancer. Clin Cancer Res 2007, 13:6649-57.24. World Health Organization: Histological Typing of Lungand PleuralTumours. Geneva, Switzerland: ... isoforms, PTEN and PI3K in tumorepithelial cells and stromal compartment in non -small celllung cancer. Anticancer Res 2009, 29:4175-83.28. Al-Saad S, Al-Shibli K, Donnem T, Andersen S, Bremnes ... histology. LungCancer 2010.31. Donnem T, Al-Saad S, Al-Shibli K, Andersen S, Busund LT, Bremnes RM:Prognostic impact of platelet-derived growth factors in non -small cell lungcancer tumor and stromal...
... Staging of small cell and non -small celllung cancer. University of Iowa Virtual Hos-pital; 1999. 6. Hopwood P, Stephens RJ: Symptoms at presentation for treat-ment in patients with lung cancer: ... the most life-threatening form of cancer in Scot-land [2]. Lungcancer is also a major cause of deaththroughout the rest of the world [3,4].Non -small celllungcancer (NSCLC) has a poor progno-sis. ... diseaseprogression and severe toxicities in NSCLC.BackgroundIn 2002, approximately 29,000 people died from lung cancer in England and Wales[1] and it is the most com-mon and the most life-threatening...
... Lung cancer is one of the most common human cancers and the leading cause of cancer death world-wide (1). Lungcancer is generally classified into two histological types, smallcelllungcancer ... gefitinib in non -small celllungcancer cell lines. Mol Cancer Res. 2006; 4(8): 521-8. 102. Taguchi F, Solomon B, Gregorc V, et al. Mass spectrometry to classify non -small- celllungcancer patients ... factor receptor and non -small- celllung cancer. J Med Genet. 2007; 44(3): 166-72. 41. Riely GJ, Pao W, Pham D, et al. Clinical course of patients with non -small celllungcancerand epidermal...
... byfirst-line chemotherapy with single agentdocetaxel in a patient with advanced non small celllung cancer Ferdinando Riccardi1*, Giuseppe Di Lorenzo1, Carlo Buonerba1, Guglielmo Monaco2, ... treatment.IntroductionIn non -small celllungcancer (NSCLC), mediastinallymphnode involvement comprises a wide spectrum ofseverity. In fact, while 9% of patients with IIIA-N2NSCLC is candidate for surgery ... Carteni’1AbstractBackground: Defining the optimal treatment for patients with inoperable non smallcelllungcancer (NSCLC),presenting with metastatic mediastinal lymph nodes, is challenging. Nevertheless,...
... non -small celllung cancer. LungCancer 2003,41:1-11.17. Shibamoto Y, Yukawa Y, Tsutsui K, Takahashi M, Abe M: Variation in thehypoxic fraction among mouse tumors of different types, sizes, and sites. ... non -small- celllung cancer: clinical implications. Radiother Oncol2010, 94:1-11.27. Chen Y, Guo W, Lu Y, Zou B: Dose-individualized stereotactic bodyradiotherapy for T1-3N0 non -small celllung ... (SBRT) for lung t umorswasintroducedinthemid1990s[1],andithasbeenperformed in many institutions as a new treatmentmodality for stage I primary lungcancerand oligometa-static lung cancer. Promising...
... Stereotactic Body Rad iotherapy, Oligometastases, Non -Small CellLung Cancer BackgroundNon -small celllungcancer (NSCLC) is the leadingcause of cancer mortality in the United States [1].Patients ... limited stage IV non -small celllung cancer Praveena Cheruvu1, Su K Metcalfe1, Justin Metcalfe1, Yuhchyau Chen1, Paul Okunieff2 and Michael T Milano1*AbstractBackground: Standard therapy ... Milano1*AbstractBackground: Standard therapy for metastatic non smallcelllungcancer (NSCLC) includes palliative systemicchemotherapy and/ or radiotherapy. Recent studies of patients with limited...
... surgery in patients withoperable lung cancer. A randomized phase III trial of Radiosurgery Or Surgeryfor operable Early stage (stage 1A) non -small cell Lung cancer (ROSEL, ClinicalTrials.gov ... and theDutch LungCancer Research Group. The primary studyobjectives are to compare local and regional control, qual-ity of life and treatment costs at 2 and 5 years in patientswho are randomized ... Therefore, an additional planning study wasperformed in 22 stage IA and 4 stage 1B non -small cell lungcancer patients in order to develop and evaluate theplanning guidelines differentiated according...